AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W909. A total of 3 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $818 | +278.7% | 67,300 | +291.3% | 0.00% | – |
| Q2 2023 | $216 | -35.7% | 17,200 | -43.2% | 0.00% | – |
| Q1 2023 | $336 | +387.0% | 30,300 | +431.6% | 0.00% | – |
| Q4 2022 | $69 | -100.0% | 5,700 | -77.5% | 0.00% | – |
| Q3 2022 | $264,000 | -84.9% | 25,300 | -84.5% | 0.00% | -100.0% |
| Q2 2022 | $1,754,000 | +1466.1% | 163,400 | +1273.1% | 0.00% | – |
| Q1 2022 | $112,000 | -60.3% | 11,900 | -51.4% | 0.00% | – |
| Q4 2021 | $282,000 | -17.1% | 24,500 | -29.0% | 0.00% | – |
| Q3 2021 | $340,000 | -0.3% | 34,500 | -2.5% | 0.00% | – |
| Q2 2021 | $341,000 | -47.9% | 35,400 | +5239.4% | 0.00% | -100.0% |
| Q1 2021 | $655,000 | -86.0% | 663 | -67.2% | 0.00% | -83.3% |
| Q4 2020 | $4,664,000 | +236.5% | 2,020 | +105.7% | 0.01% | +200.0% |
| Q3 2020 | $1,386,000 | +114.9% | 982 | +129.4% | 0.00% | +100.0% |
| Q2 2020 | $645,000 | +281.7% | 428 | +133.9% | 0.00% | – |
| Q1 2020 | $169,000 | -47.4% | 183 | -44.5% | 0.00% | -100.0% |
| Q4 2019 | $321,000 | +483.6% | 330 | +378.3% | 0.00% | – |
| Q3 2019 | $55,000 | -89.5% | 69 | -83.6% | 0.00% | -100.0% |
| Q2 2019 | $526,000 | -42.5% | 422 | -37.3% | 0.00% | -66.7% |
| Q1 2019 | $915,000 | +486.5% | 673 | +312.9% | 0.00% | – |
| Q4 2018 | $156,000 | -87.5% | 163 | -84.2% | 0.00% | -100.0% |
| Q3 2018 | $1,250,000 | -60.3% | 1,034 | -48.7% | 0.00% | -66.7% |
| Q2 2018 | $3,148,000 | +3692.8% | 2,016 | +422.3% | 0.01% | +200.0% |
| Q1 2018 | $83,000 | +112.8% | 386 | +2.1% | 0.00% | +100.0% |
| Q4 2017 | $39,000 | -71.3% | 378 | +8.9% | 0.00% | -66.7% |
| Q3 2017 | $136,000 | +223.8% | 347 | +132.9% | 0.01% | +200.0% |
| Q2 2017 | $42,000 | +23.5% | 149 | -48.6% | 0.00% | +100.0% |
| Q1 2017 | $34,000 | -50.0% | 290 | -79.4% | 0.00% | -75.0% |
| Q4 2016 | $68,000 | -34.0% | 1,408 | +252.9% | 0.00% | -42.9% |
| Q3 2016 | $103,000 | +58.5% | 399 | -8.3% | 0.01% | +75.0% |
| Q2 2016 | $65,000 | +14.0% | 435 | -47.8% | 0.00% | -20.0% |
| Q1 2016 | $57,000 | +216.7% | 833 | +100.2% | 0.01% | +400.0% |
| Q4 2015 | $18,000 | +50.0% | 416 | +152.1% | 0.00% | 0.0% |
| Q3 2015 | $12,000 | -29.4% | 165 | +33.1% | 0.00% | 0.0% |
| Q2 2015 | $17,000 | -19.0% | 124 | -43.1% | 0.00% | -50.0% |
| Q1 2015 | $21,000 | -16.0% | 218 | +129.5% | 0.00% | -33.3% |
| Q4 2014 | $25,000 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,020 | $4,664,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 123,700 | $2,856,000 | 0.01% |
| JPMORGAN CHASE & CO | 257,500 | $5,946,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |